Dr. John Wang, MD

Dr. Wang practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

Dr. Wang's NPI, 1922636596, was assigned on March 30, 2020. Dr. Wang holds New Jersey license 25MA12269800.

Dr. Wang's primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.

Dr. Wang's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Wang is also affiliated with Cooper University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Wang to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Wang is licensed in New Jersey.

CMS data shows 59 Medicare services from Dr. Wang across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $5,733 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Wang in 2024. The largest group is under 65, with 16 patients. 75% of them have anxiety, and 75% have depression. 61% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 51, with 43% women.

In 2024, Dr. Wang wrote 378 Medicare Part D claims for 67 patients. 98% of them were for generic drugs. CMS names the drug for 202 of them, across 10 drugs with 11 or more claims each, at $2,445 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 10 papers to Dr. Wang, published from 2013 to 2022. 2017 was the busiest year, with 2. The most frequent topics are Cell Movement, Chemokine CXCL12 and Signal Transduction. Dr. Wang has published most often in Sci Rep. Dr. Wang's most frequent co-authors are Weiguo Liu, MD, PhD and Samantha Ruff, MD.

CMS Open Payments shows 3 general payments to Dr. Wang from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $33.